M&R Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $313K | Buy |
673
+48
| +8% | +$22.3K | 0.07% | 106 |
|
|
2024
Q2 | $293K | Buy |
625
+100
| +19% | +$46.9K | 0.07% | 106 |
|
|
2024
Q1 | $219K | Buy |
525
+301
| +134% | +$126K | 0.05% | 123 |
|
|
2023
Q4 | $91.1K | Buy |
224
+200
| +833% | +$81.4K | 0.02% | 205 |
|
|
2023
Q3 | $8.35K | Hold |
24
| – | – | ﹤0.01% | 403 |
|
|
2023
Q2 | $8.45K | Hold |
24
| – | – | ﹤0.01% | 404 |
|
|
2023
Q1 | $7.56K | Hold |
24
| – | – | ﹤0.01% | 409 |
|
|
2022
Q4 | $6.93K | Buy |
+24
| New | +$6.93K | ﹤0.01% | 394 |
|
|
2020
Q4 | – | Sell |
-100
| Closed | -$27K | – | 471 |
|
|
2020
Q3 | $27K | Hold |
100
| – | – | 0.01% | 291 |
|
|
2020
Q2 | $29K | Hold |
100
| – | – | 0.01% | 283 |
|
|
2020
Q1 | $23K | Hold |
100
| – | – | 0.01% | 295 |
|
|
2019
Q4 | $21K | Hold |
100
| – | – | ﹤0.01% | 334 |
|
|
2019
Q3 | $16K | Hold |
100
| – | – | ﹤0.01% | 375 |
|
|
2019
Q2 | $18K | Hold |
100
| – | – | ﹤0.01% | 367 |
|
|
2019
Q1 | $17K | Hold |
100
| – | – | ﹤0.01% | 375 |
|
|
2018
Q4 | $16K | Hold |
100
| – | – | ﹤0.01% | 373 |
|
|
2018
Q3 | $19K | Hold |
100
| – | – | ﹤0.01% | 381 |
|
|
2018
Q2 | $16K | Hold |
100
| – | – | ﹤0.01% | 398 |
|
|
2018
Q1 | $16K | Hold |
100
| – | – | ﹤0.01% | 408 |
|
|
2017
Q4 | $14K | Hold |
100
| – | – | ﹤0.01% | 420 |
|
|
2017
Q3 | $15K | Hold |
100
| – | – | ﹤0.01% | 418 |
|
|
2017
Q2 | $15K | Hold |
100
| – | – | ﹤0.01% | 411 |
|
|
2017
Q1 | $10K | Sell |
100
-5
| -5% | -$500 | ﹤0.01% | 447 |
|
|
2016
Q4 | $7K | Hold |
105
| – | – | ﹤0.01% | 466 |
|
|
2016
Q3 | $9K | Buy |
105
+5
| +5% | +$429 | ﹤0.01% | 442 |
|
|
2016
Q2 | $8K | Buy |
+100
| New | +$8K | ﹤0.01% | 447 |
|